Researchers across Europe, including the UK's National Physical Laboratory , have demonstrated how an incredible material, graphene, could hold the key to the future of high-speed electronics, such as micro-chips and touchscreen technology.

Scientists at the Massachusetts Institute of Technology have designed the first submicroscopic nanoparticle that acts as an intelligent pill.

Industry advisory group Mini-IGTN has called on the Government to broaden its funding of nanotechnology exploitation.

DENVER, BUSINESS WIRE -- With unprecedented speed, the U.S. Patent Office has issued a notice of allowance to RavenBrick for 54 of 54 patent claims for its RavenWindow solar heat blocking window filter technology.

The new report " Nanotechnology: a UK Industry View " finally surfaced, and its recommendations are to spend more money, develop more skills, have more dialogue and..sorry, I must have nodded off, but it's pretty standard stuff, and the recommendations are exactly the same as every other nanotech report produced over the past ten years.

The UK House of Lords science and technology select committee has called for more research into the use of nanomaterials in food and criticised the food industry for failing to be open about its use of nanotechnology.

A research paper that has potential implications for homeland defense, work place safety, and health care has been published in the Journal of Advanced Materials and reported by materialsviews.com . The latter is a materials news service that highlights frontier research appearing in top Wiley journals in the field of materials ranging from the ...

Here's an interesting snippet from an FT report about a forthcoming report by the UK Knowledge Transfer Network on nanotechnologies The report found that UK investment in nanotechnology was low.

The nanotechnology industry has called on the government to take the lead in co-ordinating all nanotechnology activities across the UK.

BIND Biosciences, Inc . , a privately held biopharmaceutical company developing targeted therapeutics capable of differential delivery and controlled drug exposure to diseased tissue, announced today that it has secured an $11 million Series C financing.